While not pinpointing the specific ligand activating MyD88 signaling in T cells, they determined that the reduced GVHD was independent of IL-1R and TLR4 signaling, since knocking out these receptors on donor T cells did not provide the same protection (18). Here, MYD88 is linked to graft versus host disease.